Gullo C, et. al. Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cells by CD137 Ligand Signaling. Plos One 23 May, 2010
Liew PX, Feng G, Gullo C, Teoh G, William YK Hwang. Use of phage display to isolate specific human monclonal antibody fragments against a potential target for multiple myeloma. Ann Acad Med Singapore. 2009 Jul;38(7):621-9.
Qi Feng, Grace Yee Hui Ho, Charlene Jia Jia Han, Charles Gullo, Ping Law, Steven John Sobak, MBA, William Ying Khee Hwang. Ex Vivo Expansion of Haematopoietic Stem/Progenitor Cells for Pooled Cord Blood Transplantation. SGH Proceedings 2008 Vol. 17 no. 2:73-78.
Gullo C. Low WK and Teoh G. The association of EBV to Nasopharyngeal Carcinoma (NPC) and the current status on the development of NPC cell lines. Annals Academy of Medicine, Singapore. 2008; 37 769-777.
Gullo C, Feng G, Cow G, and Teoh G. Ku86 exists as a full length and natural truncated variant in multiple myeloma cells. Cancer Cell International, 2008 Apr 29;8(1):4
Gullo C, Hwang W, Poh C, Au M, Cow G and Teoh G Use of Ultraviolet Light Irradiated Multiple Myeloma Cells as Immunogens to generate Tumor Specific Cytolytic T Lymphocytes. Journal of Immune Based Therapy and Vaccines, 2008 Apr 28;6(1):2.
Gullo C, Poh C, See K, Chua C, Hwang W, and Teoh G. A Rapid and Sensitive Method of Detecting and Quantifying Hotspot Mutations in the Abelson Tyrosine Kinase Domain of the brc/abl Gene Translocation in Chronic Myeloid Leukemia. Annals Academy of Medicine Singapore Oct. 2006. 35(10); 680-687.
Hwang W*, Gullo C*, Shen J, Poh CK, Tham SC, Cow G, Au M, Chan EWE, and Teoh G. Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Line. Leukemia 2006. April 20;(4):715-23. * Co-1st Author
Morra M., Barrington RA, Abadia-Molina AC., Okamoto S., Gullo C., et al. Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci USA 2005 29; 102(13): 4819-23.
Okamoto S, Ji H, Howie D, Clarke K, Gullo C et al. Expression of the SH2D1A gene is regulated by a combination of transcriptional and post-transcriptional mechanisms. Eur J Immunol. 2004 Nov; 34(11): 3176-86.
Yong LT., Gullo C., Hwang W., and Teoh G. The Role of Cytolytic T Lymphocytes in the Eradication of Multiple Myeloma. SGH Proceedings 2004 Vol. 13 no. 2:106-112.
Wang N., Satoskar A., Sweeny R., Howie D., Gullo C. et al. The Cell Surface Receptor SLAM Controls T Cell and Macrophage Functions. J Exp Med. 2004 May 3; 199(9): 1255-64.
Howie D., Okamoto S., Rietdijk S., Clarke K., Wang N., Gullo C., et al. The Role of SAP in murine CD150 (SLAM)-mediated T cell proliferation and Interferon gamma production. Blood 2002 Oct 15;100(8):2899-907.
Wu C., Nguyen K., Pien G., Wang N., Gullo C., et al. The SAP gene controls T cell responses to virus and terminal differentiation of T helper 2 cells. Nature Immunology 2001 Vol. 2 no. 5:410
Wang N., Morra M., Wu C., Gullo C., et al. CD150 is a member of a family of genes that encode glycoprotiens on the surface of hematopoetic cells. Immunogenetics 2001 Jul; 53(5): 382
Morra M., Lu J., Poy F., Martin M., Sayos J., Calpe S., Gullo C., et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptor on Immunocytes. EMBO 2001 Nov 1(20) 21:5840
Gullo C., Esser M., Fuller T., and Braciale V. Generation of IL-2 dependent cytolytic T lymphocytes with altered T cell responses derived from antigen-dependent CTL clones. J. Immunology, 1999; 162:6466
Esser M., Krishnamurthy B., Gullo C., et al. Ca2+ Signaling modulates cytolytic T lymphocyte effector functions. J. Ex. Med 1998; 187:1057
Esser M., Haverstick D., Fuller T., Gullo C., et al. IL-2 induces Fas ligand/Fas cytotoxicity in CD8+ and CD4+ T lymphocyte clones. J Immunology, 1997; 158:5612.
Al-Laham M. and Gullo C. Uniparental disomy: A case study in cytogentics. American Society of Clinical Pathologist Tech sample. 1994; 1:1-4.
Reviews, invited published papers
Gullo C, Au M, Feng G and Teoh G. The biology of Ku and its potential oncogenic role in cancer. BBA Cancer Reviews, 2006. April 1765(2): 223-34.
Gullo C., and Teoh G. Heat Shock Proteins: to present or not, that is the question. Immunology letters 2004 94(1-2): 1-10.
Books & book chapters
Gullo C, MaCary P, and Graner M. HSP: Potent Mediators of Inflammation and Immunity, Book Chapter (The role of Heat Shock Proteins in the elicitation of immune responses. A De Maio and A. Asea (eds)). Springer 2007, vol (1) 173-187.